News

Collegium Pharmaceutical to Release 2024 Financial Results Soon

Collegium Pharmaceutical to Release 2024 Financial Results Soon

Collegium Pharmaceutical’s Upcoming Financial Reporting

Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a well-regarded biopharmaceutical company, has announced its plan to release financial results for the fourth quarter and full-year 2024. This significant milestone is scheduled for the close of the market on February 27, 2025. After the announcement, the Company intends to conduct a live conference call and a webcast for investors to discuss the results and insights into their financial performance.

Conference Call Details

The conference call is open to all interested parties, and to participate, one can simply dial (877) 407-8037 if calling from the U.S., or (201) 689-8037 for international callers. Attendees should mention the "Collegium Pharmaceutical Q4 2024 Earnings Call" to access relevant discussions. Furthermore, an audio webcast will also be available on the Company’s investor section of their official website, making it easy for stakeholders to connect and engage with the earnings announcement.

Key Information About Collegium Pharmaceutical

Collegium is on a mission to enhance the lives of individuals grappling with serious medical conditions. The Company boasts a robust portfolio centered around responsible pain management medications, which is paramount in today's healthcare landscape. Recently, Collegium improved its portfolio by acquiring Jornay PM, a groundbreaking treatment for ADHD. This acquisition marks a pivotal step in establishing a footprint in the neuropsychiatry domain, which has substantial growth potential.

Strategic Growth Initiatives

The strategic vision of Collegium includes an expansion of its commercial portfolio, with Jornay PM positioned as the flagship growth engine. The Company emphasizes a disciplined approach to capital allocation, ensuring that each investment supports their overarching goal of enhancing patient outcomes. Based in Stoughton, Massachusetts, Collegium continues to evolve and adapt, investing in innovations that resonate with their mission.

Staying Connected with Stakeholders

To maintain a clear line of communication with investors and the media, Collegium has established dedicated contacts for inquiries. Danielle Jesse, the Director of Investor Relations, leads efforts to provide shareholders with timely updates regarding the Company's financial health and strategic goals. Meanwhile, for broader media engagements, Cheryl Wheeler serves as the head of corporate communications, ensuring that all public messaging aligns with Collegium's values and objectives.

Getting in Touch

Investors looking to communicate with Collegium can reach out via email at ir@collegiumpharma.com. For media-related inquiries, they may contact Cheryl Wheeler at communications@collegiumpharma.com. These lines of communication help ensure that interested parties receive accurate and up-to-date information, reflecting the Company’s commitment to transparency.

Frequently Asked Questions

What financial results will Collegium Pharmaceutical announce?

Collegium will report its financial results for the fourth quarter and full year of 2024 during a dedicated conference call.

How can I participate in the conference call?

You can join the conference call by dialing (877) 407-8037 for U.S. callers or (201) 689-8037 for international callers.

What makes Collegium Pharmaceutical unique?

Collegium focuses on responsible pain management and has recently expanded into ADHD treatments, showcasing its commitment to diverse therapeutic areas.

Where is Collegium Pharmaceutical located?

The headquarters of Collegium Pharmaceutical is located in Stoughton, Massachusetts.

How can I contact Collegium for investor relations?

For investor-related questions, you can reach out to Danielle Jesse at ir@collegiumpharma.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 1

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 2

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 2

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading
Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 0

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 1

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 0

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
The Austin Company to Showcase at ISPE Annual Event

Updated Category News Views 2

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 1

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
Facility Solutions Group Climbs to Top 18 Electrical Spot

Updated Category News Views 0

FSG Shines Brightly in Electrical Contractor Rankings Climbing the ladder is no easy feat, but Facility Solutions Group (FSG) has managed to climb, all the way to the #18 spot on Electrical Construction & Maintenance (EC&M) magazine's revered list of the Top Electrical Contractors in the U.S. It’s up from their previous rank of 22. When you think about the competitive...

Continue Reading

Top 5 Most Recently Viewed Articles

Kamala Harris to Launch Wealth-Building Economic Strategies

Updated Category News Views 64

Kamala Harris to Unveil Economic Strategies for Wealth Building As the election approaches, Vice President Kamala Harris is preparing to reveal new economic policies this week, focusing heavily on wealth creation. Plans for Economic Growth The details of these proposals are expected to be shared midweek. They aim to clarify Harris’s economic vision for undecided voters...

Continue Reading
Marpai to Stream Key Financial Updates for Q2 2025

Updated Category News Views 103

Marpai to Host Important Webcast for Financial Results Marpai, Inc. (MRAI), recognized for its innovative healthcare technology, is all set to hold a critical conference call and webcast soon to discuss its financial performance. The company aims to present operational insights and financial highlights for the second quarter of 2025. This is an important moment for the...

Continue Reading
Cabinet Joint Maintains Prices Amid Rising Tariffs Challenges

Updated Category News Views 340

Cabinet Joint Maintains Competitive Pricing in Changing Market Online cabinetry company absorbs costs from new U.S. import tariffs to protect homeowners' renovation budgets As new tariffs come into play under recent trade initiatives, Cabinet Joint, a prominent provider of premium ready-to-assemble (RTA) cabinetry, has made a strategic decision to keep its prices stable....

Continue Reading
American Properties Enhances Homebuilding Vision at Key Event

Updated Category News Views 136

American Properties Improves Insights at Builder Show Company leaders recently participated in a significant event, exploring trends and innovations that greatly influence the future of homebuilding. Key Participation at the International Builders' Show American Properties took part in a prominent event showcasing the homebuilding industry, with over 76,000 professionals...

Continue Reading
Avid Bioservices Updates Investors on Convertible Notes Changes

Updated Category News Views 134

Avid Bioservices Informs Investors About Changes to Convertible Notes Avid Bioservices, Inc., a prominent biologics contract development and manufacturing organization, has recently communicated critical updates regarding its 7.00% Convertible Senior Notes due 2029. These announcements relate directly to the company's recent merger activities aimed at enhancing its...

Continue Reading